Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
azelastine hydrochloride, Quantity: 0.206 mg/actuation
Viatris Pty Ltd
Azelastine hydrochloride
Spray, nasal
Excipient Ingredients: sucralose; benzalkonium chloride; hypromellose; sodium citrate dihydrate; purified water; disodium edetate; sorbitol solution (70 per cent) (crystallising)
Nasal
4 mL, 30 mL
(S2) Pharmacy Medicine
For the symptomatic treatment of seasonal allergic rhinitis, perennial allergic rhinitis.
Visual Identification: Clear, colourless solution filled into opaque high-density polyethylene (HDPE) bottles and fitted with screw-on metered-spray pump closures.; Container Type: Aerosol - Pump Actuated Metered Dose; Container Material: HDPE; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Restricted flow insert
Licence status A
2013-12-11